EnLiSense LLC – Trademark Portfolio

Entity Type: 16

EnLiSense LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 5 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 2 are pending. Notable registered marks include ENLISENSE, IBD AWARE, and SWEAT AWARE. The owner is based in Allen, TX.

1813 Audubon Pond Way

Allen, TX 75013

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

EnLiSense LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (5 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does EnLiSense LLC have?

EnLiSense LLC has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 pending.

What trademark classes does EnLiSense LLC file in?

EnLiSense LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are EnLiSense LLC's most well-known trademarks?

EnLiSense LLC's registered trademark portfolio includes well-known marks such as ENLISENSE, IBD AWARE, and SWEAT AWARE. These are among 3 currently registered trademarks in the portfolio.

What is EnLiSense LLC's trademark registration success rate?

EnLiSense LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 2 applications are pending review.